Использование новых подходов к оценке типовой принадлежности и функциональных особенностей мускариновых рецепторов различных отделов головного мозга
Диссертация
При изучении роли модуляции уровня вторичных посредников в секреции ацетилхолина было установлено, что изменения содержания ацетилхолина в ткани ствола головного мозга под действием хлорида лития не происходит. Таким образом, можно сделать вывод, что пресинаптические ауторецепторы ствола головного мозга крыс не связаны с фосфоинозитидной системой вторичных посредников. Напротив, повышение… Читать ещё >
Список литературы
- Афифи А., Эйзен С. Статистический анализ. Подход с использованием ЭВМ. // М., 1982. — 322 с.
- Голиков С.Н. О сотношении центрального и периферического действия атропина в подавлении некоторых симптомов ареколи-новой интоксикации у мышей. // Фармакол. токсикол. — 1956. — N2,—С. 36−42.
- Долго-Сабуров В. Б., Шорохов Ю. А. Молекулярные механизмы функционирования мускариновых холинорецепторов // Итоги науки и техники. ВИНИТИ. Фармакология. Химиотерапевт, средства. 1989, —Т. 19, —155 с.
- Зеймаль Э. В., Шелковников С. А. Мускариновые холинорецепторы /7 Л. «Наука»., 1989. — 288 с.
- Космачев А. Б., Янхонтова М. Б., Космачева И. М. Селективность и защитные свойства М-холинолитиков при отравлении дихлор-дивинилфосфатом // Эксперим. и клин, фармакол. — 1992. — Т. 5, N3,—С. 56−58.
- Кузнецов С. Г., Рамш С. М., Змывалова А. Г. Селективные лиганды подтипов мускариновых холинорецепторов// Итоги науки и техники.
- ВИНИТИ. Фармакология. Химиотерапевт, средства. — М., 1991. — Т. 25. — С. 84−209.
- Либман Н. М., Кузнецов С. Г., Локтионов С. И., Голиков С. Н., Пашкевич Б. П., Зацепин Э. В. Аминоспирты ацетиленового ряда. XI. Синтез и холинолитические свойства 1-фенил-1-циклоапкиламино-2-бутин-1-ола//Химико-фармацевт. ж. — 1998. —N 12. — С. 21−25.
- Машковский М. Д. Лекарственные средства // М.: «Медицина», 1988, — 575 с.
- Подосиновикова Н. П., Долго-Сабуров В. Б. Некоторые механизмы регуляции синтеза и секреции ацетилхолина в холинергических терминалях мозга // Нейрохимия. — 1992. — Т. 11, N 2. — С. 3−7.
- Подосиновикова Н. П., Горобец Л. Ф., Долго-Сабуров В. Б. Типовая принадлежность пресинаптических М-холинорецепторов различных отделов мозга крыс // Бюлл. эксперим. биол. и мед. — 1996. — Т. 122, N7, —С. 75−77.
- Прозоровский В. Б., Прозоровская М. Л., Демченко В. Н. Экспресс-метод определения средней эффективной дозы и ее ошибки. // Фармакол. токсикол. — 1978. —N4. — С. 56−58.
- Селиванова А. Т., Голиков С. Н. Холинергические механизмы высшей нервной деятельности. //Л.: «Медицина», 1975. — 184 с.
- Скок В. И. Селянко А. А., Дергач В. А. Нейрональные холинорецепторы. /УМ.: Наука, 1986. — 343 с.
- Шел ко в ни ко в С. А. Новые данные о гетерогенности мускариновых холинорецепторов // Итоги науки и техники. ВИНИТИ. Фармакология. Химиотерапевт, средства. — М., 1991. — Т. 25. — С. 1−83.
- Adem A., Bogdanovic N., islam A., Jolkkonen М., Winblad В., Karlsson Е. Distribution of М4 muscarinic cholinergic receptors in the rat brain detected by a selective mamba toxin (MT-3) // Life Sci. —- 1995. — Vol. 6, N 11/12, Abstr. 23,—P. 1013.
- Akbulut H., Akin S. В., Goren Z., Ozdemir O., Oktay S. Distinct functional muscarinic receptor subtypes in rat atrium and guinea-pig gall bladder // Life Sci. 1995. — Vol. 6, N 11/12, Abstr. 75. — P. 1039.
- Ashkenazi A., Peralta E. G., Winslow J. W., Ramachandran J., Capon D. J. Functional diversity of muscarinic receptor subtypes in cellular signal transduction and growth // Trends Pharmacol. Sci. 1989. — Vol. 10. Suppl. — P. 16−21.
- Atkins G. L. A simple digital-computer program for estimating the parameters of the Hill equation. // Eur. J. Biochem. — 1973. — Vol. 33, No. 1, —P. 175−180.
- Baghdoyan H. A. Location and quantification of muscarinic receptor subtypes in rat pons implications for REM sleep generation // Am. J. Physiol. — 1997. — Vol. 273, N 3. — R896-R904.
- Baghdoyan H. A., Lydic R. Fleegal M. A. M: Muscarinic autoreceptors modulate acetylcholine release in the medial pontine reticular formation /У J. Pharmacol. Exp. Ther. — 1998. — Vol. 286, N 3. — P. 1446−1452.
- Bartus R. A., Dean R. L. Ill, Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunctions //' Science. — 1982. — Vol. 217, N4557.— P. 408−417.
- Baumgold J., Paek R., Fiskum G. Calcium independence of phosphoinositide hydrolysis — induced increase in cyclic AMP accumulation in SK-N-SH human neuroblastoma cells // J. Neurochem.1992.—Vol. 8. — P. 1754−1759
- Birdsall N. J. M., Burgen A. S. V., Hulme E. C. The binding of agonists to brain muscarinic receptors /7 Mol. Pharmacol. — 1978. — Vol. 14, N. 51. P. 723−736.
- Birdsall N. J. M., Hulme E. C. Muscarinic receptor subclasses // Trends Pharmacol. Sci. — 1983. — Vol. 4, N 1 1. — P. 459−463.
- Birdsall N. J. ML, Hulme E. C. Stockton J. M. Muscarinic receptor subclasses: allosteric interactions /7 Mol. Neurobiol. — 1983. — Vol. 48.1. P. 53−56.
- Bolton T. B., Zholos A. V. Activation of M2 muscarinic receptors in guinea-pig ileum opens cationic channels modulated by M3 muscarinic receptors//Life Sci. — 1997.— Vol. 60, N 13/14. — P. 1121−1128.
- Bonner T. L, Buckley N. J., Young A. C. Brann M. R. Identification of a family of muscarinic acetylcholine receptor genes// Science. — 1987. — Vol. 237. N 4814. — P. 527−532.
- Brann M. R., Buckley N. J. Bonner T. 1. The striatum and cerebral cortex express different muscarinic receptor mRNA’s / FEBS Letts. — 1988. — Vol. 230, —P. 90−94.
- Brown D. A., Forward A., Marsh S. Antagonist discrimination between ganglionic and ileal muscarinic receptors // Brit. J. Pharmacol. — 1980. — Vol. 71, N 2. — P. 362−364.
- Candura S. M., Tonini M., Baiardi P., Manzo L., Costa L. G. Heterogeneity of cholinergic muscarinic receptors coupled to phosphoinositide metabolism in immature rat brain// Development. Brain Res. — 1995. — Vol. 86. — P. 134−142.
- Cantalamessa F., Angeli P., Melchiorre C. Tripitramine: further pharmacological evaluation in pithed rat // Life Sci. — 1995. — Vol. 6, N 11/12, Abstr. 20. —P. 1012.
- Caulfield M. P. Muscarinic receptors: characterization, coupling and function // Pharmacol. Ther. — 1993. — Vol. 58. — P. 3 19−379
- Caulfield M. P., Birdsall N. J. M. Classification of muscarinic acetylcholine receptors /7 Pharmacol. Rev. — 1998. — Vol. 50, N 2. — P. 279−290.
- Christie M. J., North R. A. Control of ion conductance by muscarinic receptors // TIPS. — 1988. — Vol. 9. Suppl. — P. 30−34.
- Costa P., Traver D. J., Auger C. B., Costa L. G. Identification of in-, m4, ms subtypes of muscarinic receptor mRNA in human blood mononuclear cells//Life Sci. —Vol. 6, N 11/12, Abstr. 35. — P. 1019.
- Consolo S., Ladinsky H., Vinci R., Palazzi E., Wang J. X. An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum /7 Biochem. Pharmacol. — 1987. — Vol. 36, N 18. — P. 3075−3077.
- Crossland J. Slater P. The effect of some drugs on the «free» and «bound» acetylcholine content of rat brain Brit. J. Pharmacol, and Chemother. 1968. — Vol. 33. — P. 42−47.
- D’Agostino G., Barbieri A., Grana E., Subissi A. Characterization of prejunctional muscarinic autoreceptors in the rat urinary bladder // Life Sci. — 1993, —Voi. 52. — ?. 80.
- D’Agostino G., Barbieri A., Chiossa E., Tonini M. M4 muscarinic autoreceptor-inediated inhibition of JH. acetylcholine release in the rat isolated urinary bladder // J. Pharmacol. Exp. Ther. — 1997. — Vol. 283, N 2. — P. 750−756.
- Darroch S., Mitchelson F. Characterization of a novel muscarine receptor in avian smooth muscle /7 Life Sci. — 1995. — Vol. 6, N 11/12, Abstr. 78, —P. 1010
- Dolezal V., Tucek S. Role of depolarization and calcium ions in the inhibition of acetylcholine release by presynaptic muscarinic autoreceptors /7 Physiol. Res. — 1993. — Vol. 42, N. 4 — P. 140.
- Doods H., Entzeroth M., Ziegler H., Schiavi G., Engel VV., Mihm G., Rudolf K., Eberlein W. Characterization of BIBN 99: a lipophilic and selective muscarinic M: receptor antagonist. // Eur. J. Pharmacol. — 1993,—Vol. 242, N 1. — P. 23−30.
- Dorje F. Wess J., Lambrecht G. Tacke R., Mutschler E. Brann N4. R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes // J. Pharmacol. Exp. Ther., — 1991. — Vol. 256, N 2. — P. 727−733.
- Eglen R. M" Reddy H., Watson N" Challiss R. A. J. Muscarinic acetylcholine receptors and control of smooth muscle tone // Trends Pharmacol. Sci. — 1994. — Vol. 15, N 11. — P. 407−408.
- Ehlert F. J., Roeske W. R., Yamamura H. J. Muscarinic receptors and novel strategies for the treatment of age-related brain disordes // Li fe Sci.1994, —Vol. 55, N 25/26, —P. 2135−2145.
- Ehlert F. J., Thomas E. A. Functional role of M2-muscarinic receptors in the guinea pig ileum // Life Sci. -1995. -Vol. 56, N 11/12. — P. 965−971.
- Ellis J., Huvler J. H., Kemp D. E., Weiss S. Muscarinic receptors and second-messenger responses of neurones in primary cultures // Brain Res.1990. — Vol. 511, N 2, —P. 234−240.
- Entzeroth M., Mayer N. Labelling of rat heart muscarinic receptors using the new M2 selective antagonist -H.AF-DX 384 /7 Biochem. Pharmacol.1990, — Vol. 40, N 1. — P. 1674−1676.
- Esqueda E. E., Gerstin E. H. J-, Griffin M. T., Ehlert F. J. Stimulation of cyclic IMP accumulation and phosphoinositide hydrolysis by M3-muscarinic receptors in the rat peripheral lung /7 Biochem. Pharmacol. — 1996. — Vol. 52. — P. 643−658.
- Evans T., Smith M. M., Tanner L. T., Harden T. K. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms /7 Mol. Pharmacol. — 1984. — Vol. 26, N 3. — P. 395−404.
- Exposito I., Oakin S., Mora F. Decrease of extracellular aspartic acid concentration produced by a Vf muscarinic receptor agonist in the striatum of the concious rat. J. Physiol. Proc. — 1990. — N 493. — P. 1 S.
- Ferrari-Dileo G" Waelbroeck M. Mash D. C. Flynn D. D. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype, 7 Mol. Pharmacol. — 1994. — Vol. 46. N 6. — P. 1028−1035.
- Forray C, El-Fakahany E. E. Mediation of phosphoinositide metabolism in rat cerebral cortex by M, and Mo muscarinic receptors // Trends Pharmacol. Sci. —1989. —Vol. 10, Suppl. — P. 111.
- Fukuda K., Kubo T., Maeda A., Akiba I., Bujo H., Nakai J., Mishina ML, Higashida H., Neher E., Marty A., Numa S. Selective effector coupling of muscarinic acetylcholine receptor subtypes // Trends Pharmacol. Sci. — 1989.—Vol. 10, Suppl. —P. 4−10.
- Giachetti A., Micheletti R., Montagna E. Cardioselective profile of AF-DX 116, a muscarinic M2-receptor antagonist // Life Sci. — 1986. — Vol. 38. N 18.—P. 1663−1672.
- Giraldo E., Micheletti R., Montagna E., Giachetti A., Vigano M. A., Ladinsky H., Melchiorre C. Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine // J. Pharmacol. Exp. Ther. — 1988, —N 3, —P. 1016−1020.
- Graybiel A. M., Ragsdale C. W. Biochemical anatomy of the striatum // Chemical Neuroanatomy (Emson P. C. ed.) — Raven Press, New York. — P. 427−504.
- Gross J., VVaelbroek M., Mutschler E., Lambrecht G. Functional characterization of neuronal muscarinic receptors in rabbit annococcygeus muscle// Life Sci. — 1995, — Vol. 56, N 11/12. Abstr. 73, —P. Iu38.
- Hammer R., Berrie C. P., Birdsall N. J. M" Burgen A. S. V., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors // Nature. — 1980. — Vol. 183, N 5742. — P. 90−91.
- Hammer R., Giachetti A. Selective muscarinic receptor antagonists // Trends Pharmacol. Sci. — 1984. — Vol. 5. N 1. P. 18−20.
- Hammer R. Giraldo E., Schiavi G. B. Monfenni E. Ladinski H. Binding profile of a novel cardioselective muscarine receptor antagonist. AF-DX 1 16. to membranes of peripheral tissues and brain in the rat /, Life Sci.—1986. —Vol. 38, N 18, —P. 1653−1662.
- Hersch S. M., Levey A. I. Diverse pre- and post-synaptyc expression m,-m4 muscarinic receptor proteins in neurons and afferents in the rat neostriatum // Life Sci. — 1995. — Vol. 56, N 11/12. — P. 931−938.
- Hosey M. M. Diversity of structure, signaling and regulation within the family of muscarinic cholinergic receptors // FASEB J. — 1992. — Vol. 6. — P. 845−852.
- Hughes A. R., Martin M. W., Harden T. K. Pertusis toxin differentiates between two mechanisms of attenuation of cyclic AMP accumulation by muscarinic cholinergic receptor // Proc. Natl. Acad. Sci. USA. — 1984. — Vol. 81. N 18, —P. 5680−5684.
- Hebb C. O., Whittaker V. P. Intracellular distributions of acetylcholine and choline acetylase /7 J. Physiol.— 1958, — Vol. 142, —P. 187−196.
- Hulme E. C. Birdsall N. J. M. Burgen A. S. V. Mehta P. The binding of antagonists to brain muscarinic receptors Mol. Pharmacol. — 1978. — Vol. 14. N. 5 — P. 737−750.
- Imeri L., Bianchi S., Angeli P., Mancia M. Selective blockade of different brainstem muscarinic receptor subtypes effects — on the sleep-wake cycle // Brain Res. — 1994. — Vol. 636, N 1. — P. 68−72.
- Jalcobs K. H., Aktories K., Shultz G. GTP-dependent inhibition of cardiac adenylate cyclase by muscarinic cholinergic agonists // Naunyn-Schiedeberg's Arch. Pharmacol. — 1979. Vol. 310, N 2. — P. 113−119.
- James M. K., Cuppedu L. X. Frequency-dependent muscarinic receptor modulation of acetylcholine and dopamine release from rabbit striatum // J. Pharmacol. Exp. Ther. — 1984. — Vol. 229, N 1. — P. 98
- Jerusalinsky D. Harvey A. L. Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors // Trends Pharmacol. Sci. — 1994. — Vol. 15, N 11. — P. 424−430.
- Kasa P. The cholinergic system in brain and spinal cord /7 Prog. Neurobiol. — 1986. — Vol. 26. — P. 211−272.
- Kenakin T. P., Boselli C. Promiscuous or geterogeneous muscarinic receptors in rat atria? 1. Schild analysis with simple competitive antagonists /7 Eur. J. Pharmacol. — 1990. — Vol. 191, N 1. — P. 39−48.1. CT «
- Kerr P. M» Hiller K., Wallis R. M" Garland C. J. Pharmacological characterization of muscarinic receptors mediating contractility in human colon//Life Sci. — 1995, —Vol. 56, N 11/12, Abstr. 82, —P. 1042.
- Kilbinger H., Halim S., Lambrecht G" Weller W., Wessler G. Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptor in the guinea-pig ileum // Eur. J. Pharmacol. — 1984. — Vol. 103. N ¾. — P. 313−320.
- Korc M., Ackennan M. S., Roeske W. R. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini//J. Pharmacol. Exp. Ther. — 1987.-Vol. 240, NL — P. 118−122.
- Lambrecht G. Feifel R. Forth B., Strohmann CA Tacke R. Mutschier E. p-Fluoro-hex.ahydro-sila-difenidol: the first M: rselectie muscarinic antagonist Eur. J. Pharmacol. — 1988.. 152. N 12. — P. 193−194.
- Lambrecht G., Gross J., Hackseil U., Hermani U. Hildebrandt C. Hou X. Moser U. Nilsson B. M" Pfaff 0., Waelbroeck M. Wehrle J. Mutschier
- E. The design and pharmacology of novel selective muscarinic agonists and antagonists // Life Sci. — 1995. — Vol. 56, N I 1/12. — P. 815−822.
- Lehman J., Langer S. Z. Muscarinic receptors on dopamine terminates in the cat caudate nucleus neuromodulation of 'H-dopamine release in vitro by endogeneous acetylcholine//Brain Res.— 1982. — Vol.248, N. P. 61.
- Levey A. I., Kitt C. A., Simonds W. F., Price D. L., Brann M. R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-selective antibodies // J. Neurosci. — 1991. — Vol. 11. — P. 3218−3226.
- Levey A. 1., Edmunds S. M., Hersch S. M., Wiley R. G., Heilman C. J. Light and electron microscopic study of in2 muscarinic acetylcholine receptor in the basal forebrain of rat // J. Comp. Neurol. — 1995. — Vol. 351, —P. 339−356.
- Levine R. R., Birdsall N. J. M. (eds) Subtypes of muscarinic receptors. Proceedings of the 7th international symposium on subtypes of muscarinic receptors // Life Sci. — 1997. — Vol. 60, N 13/14. — P. 963−1207.
- Li C. K., Mitchelson F. The selective antimuscarinic action of stercuronium // Brit. J. Pharmacol. — 1980, —Vol. 70, N 2. — P. 313−321.
- Logothetis D., Karachi Y., Galper J., Neer E. J., Clapham D. E. The subunits of GTP-binding proteins activate the muscarinic K -channel in heart // Nature. — 1987. — Vol. 325. N 6102. — P. 321−326.
- Longhurst P. A., Legget R. E., Briscoe J. A. K. Characterization of the functional muscarinic receptors in the rat urinary bladder // Brit. J. Pharmacol. — 1995, —Vol. 116, N. 4 — P. 2279−2285.
- Lowry O. H. Rosenbrough N. 1. Fan- A. L. Randall R. J. Prote in measurement with the Folin phenol reagent J. Biol. Chem. — 1951. ----Vol. 193. N 1. — P. 265−275.
- MacGeer P. L. Eceles J. C., MacGeer E. C. Molecular Neurobiology of the Mammalian Brain. — New York: Plenum Press— 1978.
- Maeda A., Kubo T., Mishina H., Nunia S. Tissue distribution of mRNA encoding muscarinic acetylcholine receptor subtypes // FEBS Lett., — 1988. — Vol. 239. — P. 339−342.
- Mash D. C., Flynn D. D., Potter L. T. Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer’s disease and experimental cholinergic denervation//Science. 1985. — Vol. 228, N 3. — P. 1115−1117.
- Max S. I., Liang J. S., Valentine H. H., Potter L. T. Use of m, toxin as a selective antagonist of m, muscarinic receptors // J. Pharmacol. Exp. Ther. — 1993. — Vol. 267, N I. P. 450−485.
- Mallios V. J., Lydic R., Baghdoyan H. A. Muscarinic receptor subtypes are differentially distributed across brain stem respiratory nuclei /7 Am. J. Phisiol. — 1995. — Vol. 268, N6, —L941−949.
- McKinney M., Richelson E. Blockade of N1E-115 murine neuroblastoma muscarinic receptor function by agents that affect the metabolism of arachidonic acid /,' Biochein. Pharmacol. — 1986. — Vol. 35, N 14. — P. 2389−2397.
- McKinney M. Miller J. H. Aagaard P. J. Pharmacological characterization of the rat hippocampal muscarinic autoreceptor / J. Pharmacol. Exp. Ther. — 1993. — Vol. 264, N 1. — P. 74.
- Miller J. H., Adgaard P. J., Gibson V. A., McKinney M. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors // J. Pharmacol. Exp. Ther. — 1992. — Vol. 263, N 2. — P. 663−667.
- Miller R. J. Presynaptic receptors // Annu. Rev. Pharmacol. Toxicol. — 1998. — Vol. 38. — P. 204−227.
- Miyoshi R., ICito S., Shimoyanra M. Quantitative autoradiographic localization of the Mi and M2 subtypes of muscarinic acetylcholine receptors in the monkey brain // Jap. J. Pharmacol. — 1989. — Vol. 51, N2. — P. 247−256.
- Monsma F. J., Abood L. G., Hoss W. Inhibition of phosphoinositide turnover by selective muscarinic antagonist in the rat striatum. Correlation with receptor occupancy /7 Ibid. — 1988. — Vol. 37, N 12. — P. 24 372 444.
- Oiianas M. C, Onali P., Neff N. H., Costa E. Adelate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists // Mol. Pharmacol. — 1983. — Vol. 23, N 2. — P. 393−398.
- Onali P., Oiianas M. C., Schwartz J. P., Costa E. Involvement of high-affinity GTP-ase in the inhibitory coupling of striatal muscarinic receptors to adenylate cyclase /7 Mol. Pharmacol. — 1983. — Vol. 24, N 3. — P. 380−386.
- Peralta E. G., Winslow J. W" Peterson G. L., Smith D. H., Ashkenazi A., Ramachandran J., Schimerlik M. I., Capon D. J. Primary structure and biochemical properties of an M2-muscarinic receptor // Science. — 1987. — Vol. 236, N 4801. — P. 600−605.
- Peralta E. G. Ashkenazi A., Winslow J. W., Ramachandran J., Capon D. J. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes // Nature. — 1988. — Vol. 334. — P. 434 437.
- Purkerson S. L., Potter L. T. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors // J. Pharmacol. Exp. Ther. — 1998. — Vol. 284, N2. — P. 707−713.
- Potter L. T., Flynn D. D., Hanchett H. E., Kalinoski D. L., Luber-Narod J., Mash D. C. Independent M, and M2 receptors: ligands, autoradiography and functions // Trends Pharmacol. Sci. — 1984. — Vol. 5. Suppl. — P. 22−31.
- Preiksaitis H. G." Launer L. G. Pharmacological and molecular characterization of muscarinic receptors in cat esophageal smooth muscle //J. Pharmacol. Exp. Ther. — 1998. — Vol. 285. N2. — P. 853−861.
- Quirion R., Richard J., Wilson A. Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adults rats 11 Synapse. — 1994. — Vol. 17, N 2. — P. 92−100.
- Raiteri M., Leardi R., Marchi M. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain // J. Pharmacol. Exp. Ther. — 1984. — Vol. 228, N 1. — P. 209−214.
- Raiteri M., Marchi M., Paudice P., Pittaluga A. Muscarinic receptors mediating inhibition of y-aminobutyric acid release in rat corpus striatum and their pharmacological characterization II J. Pharmacol. Exp. Ther. — 1990.—Vol. 254, N2.—P. 496−501.
- Raw Is S. M., McGinty J. F. Muscarinic receptors regulate extracellular glutamate levels in the rat striatum: an in vivo microdialysis study // J. Pharmacol. Exp. Ther. — 1998. — Vol. 286. N 1. — P. 91−98.
- Ray A. P., Filmor M. L., Levey A. 1., Rye D. B. Species differences and cholinergic terminal/receptor mismatch in the pontine REM-induction area II Soc. Neurosci. — 1997. — Vol. 23, Abstr. — P. 213 1.
- Richards M. H. Relative potencies of agonists and differential sensitivity to N-ethylmaleimide on muscarinic autorereceptor sand postsynaptic receptors in rat hippocampus // J. Pharmacol. Exp. Ther. — 1990. — Vol. 255, N 1. — P. 83−89.
- Riker W. F., Wescoe V. C. The pharmacology of flaxedil with observations on certain analogs. Ann. N. .Y. Acad. Sci. 1951. — Vol. 54. — P. 373−394.
- Role L. W. Kelly J. P. The brain stem: cranial nerve nuclei and the monoaminergic systems II Principles of neural science. — 3rd ed.
- Kandell E. R., Schwartz J. H., Jessel T. M. eds) — Elsevier, New York, NY. — P. 683−689.
- Roszkowski A. P. An unusual type of sympathetic ganglionic stimulant // J. Pharmacol. Exp. Ther. — 1961, —Vol. 132, N 1. — P. 156−170.
- Rouse S. T., Thomas T. M., Levey A. 1. Muscarinic acetylcholine receptor subtype, lrb.'diverse functional inplications of differential synaptic localization//Life Sci. — 1997, —Vol. 60, N 13/14.— P. 1031-1038.
- Saxena P. R., Bonta 1. L. Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blocade of cardiac muscarinic receptors // Eur. J. Pharmacol. — 1970. -Vol. 11. — P. 332−34L
- Scatchard G. The attraction of proteins for smoll molecules and ions // Ann. N.J. Acad. Sci. — 1949. — Vol. 51. — P. 660−692.
- Szerb J. C., Malik H. Hunter E. J. Relationship between acetylcholine content and release in the cat’s cerebral cortex /7 Canad. Physiol. Pharmacol. — 1970. — Vol. 8. — P. 780−790.
- Tacke R., Linoh H" Zilch H., Wess J., Moser U., Mutschler E., Lambrecht G. Synthesis and properties of the selective antimuscarinic agent cyclohexylphenyl (3-piperidinopropyl) si land /7 Lieb. Ann. Chem. — 1985,—N 11. — P. 2223−2228.
- Taylor C. W., Merrit J. E. Receptor coupling polyphosphoinositide turnover: a parallel with the adenylate cyclase system // Trends Pharmacol. Sci. — 1986. — Suppl. 1 1 — P. 238−242.
- Tietje K. M., Goldman P. S., Nathanson N. M. Cloning and functional analysis of a gene encoding a novel muscarinic acetylcholine receptor expressed in chick heart and brain 7 J. Biol. Chem. — 1990. — Vol. 265, N. 5 — P. 2828−2834.
- Velazquez-Moctezuma .). Gillin J. C7. Shiromani P. J. Effect of specific NT. M2 muscarinic receptor agonists on REM-sleep generation Brain Res. — 1989. — Vol. 503, N I. — P. 128−131.
- Vogt B. A. Localization of cortical muscarinic receptor subtypes // Ibid.1988. — Vol. 9, Suppl. — P. 49−53.
- Waelbroeck M., Tastenoy M., Camus J., Christophe J. Binding selective antagonists to four muscarinic receptors (M, to M4) in rat forebrain // Ibid.1990. — Vol. 38, N 2. — P. 267−273.
- Wallis R. M., Smith C. ML A comparison of the binding profile of antagonists at the human cloned muscarinic receptors itl. and m3 using 3H]-darifenacine and [3H]-NMS // Life Sci. — 1997. — Vol. 60, N 13/14, Abstr. 25. — P. 1 175.
- Wang S. Z., Zhu S. Z., El-Fakahany E. E. Efficient coupling of m5 muscarinic acetylcholine receptors to activation of nitric oxide synthase // J. Pharmacol. Exp. Ther. — 1994. — Vol. 268, N 2. — P. 52 557.
- Watanabe A. M., McConnaughey M. ML, Strawbridge R. A., Fleming J. WL, Jones L. R. Besch H. R. Muscarinic cholinergic receptor modulation of P-adrenergic receptor affinity for catecholamines // J. Biol. Chem. -1978. — Vol. 253, N 14. —P. 4833−4836.
- Watson M., Yamamura H. 1., Roeske W. R. A unique regulatory profile and regional distribution of /Hjpirenzepine binding in the rat provide evidence for distinct Mi and M2 muscarinic receptor subtypes // Life Sci.1983,—Vol. 32, N26.— P. 3001-3011.
- Watson N. Reddy H. Eglen R. M. Pharmacological characterization of the muscarinic receptors mediating contraction of canine saphenous vein /7 J. Auton. Pharmacol. — 1995. — Vol. 15. — P. 37−441.
- Wei J., Walton E. A., Milici A., Buccafusco J. J. mrm5 Muscarinic receptor distribution in rat CNS by RT-PCR and HPLC // J. Neurochem.1994,—Vol. 63, N 3. — P. 815−821.
- Weiner D. M., Levey A. J., Brann M. R. Expression of muscarinic acetylcholine and dopamine receptor mRN As in rat basal ganglia // Proc. Nat. Acad. Sci. USA. — 1990. — Vol. 87. — P. 7050−7054.
- Yamamura H. L, Snyder H. S. Muscarinic cholinergic binding in rat brain // Proc. Natl. Acad. Sci. USA. — 1974. — Vol. 71, N. 5 — P. 1725−1729.
- Yukihisa M., Kinzo M., Hiroyuki 0., Hiroshi W. Effects of oxotremorine and pilocarpine on striatal acetylcholine release as studieid by brain dialysis in anesthetized rats Gen. Pharmacol. — 1996. — Vol. 27. N. 51. P. 833−836.i 11